PUBLISHER: IMARC | PRODUCT CODE: 1370301
PUBLISHER: IMARC | PRODUCT CODE: 1370301
The global blood culture test market size reached US$ 4.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.
A blood culture test refers to a medical procedure that is conducted to diagnose bacterial, fungal and mycobacterial infections. It is performed for the identification of various microorganisms in the blood sample and for preventing the development of sepsis conditions. The results of the culture test can aid in determining the specific pathogens that are causing the infection and possible ways for combating the disease. It utilizes products including blood culture media, assay kits, reagents, and blood culture accessories, and instruments such as automated blood culture systems and supporting laboratory equipment.
The increasing prevalence of chronic and infectious diseases across the globe is one of the key factors driving the growth of the market. Furthermore, the growing geriatric population that is more susceptible to sepsis and other medical ailments is also providing a boost to the market growth. Additionally, the growing demand for blood culture tests to analyze specimens, due to the outbreak of the COVID-19 pandemic, is acting as another major growth-inducing factor. Laboratories, diagnostic centers and other healthcare institutes are now increasingly using these tests for detecting the presence of antibodies in the blood and identifying and isolating the infected individuals. Other factors, including the rising health consciousness among the masses, improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood culture test market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on testing medthod, product, technology, application and end-user.
Conventional
Automated
Consumables
Blood Culture Media
Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Fungi/Yeast Blood Culture Media
Mycobacteria Blood Culture Media
Assay Kits and Reagents
Blood Culture Accessories
Instruments
Automated Blood Culture Systems
Supporting Laboratory Equipment
Incubators
Colony Counters
Microscopes
Gram Stainers
Software and Services
Culture-based Technology
Molecular Technology
Microarray
PCR
PNA-FISH
Proteomic Technology
Others
Bacterial Infections
Fungal Infections
Mycobacterial Infections
Hospital Laboratories
Reference Laboratories
Research Laboratories
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, bioMeriux SA, Bruker Corporation, Luminex Corporation, Merck KGaA, Siemens Healthcare GmbH, F.Hoffmann-La Roche Ltd., T2 Biosystems Inc. and Thermo Fisher Scientific Company.